Published in EMBO J on May 20, 2004
The axonal transport of mitochondria. J Cell Sci (2005) 5.19
Axonal transport defects in neurodegenerative diseases. J Neurosci (2009) 2.74
Dynamic aspects of CNS synapse formation. Annu Rev Neurosci (2007) 2.47
Two cyclin-dependent kinase pathways are essential for polarized trafficking of presynaptic components. Cell (2010) 2.32
Axonal transport deficits and neurodegenerative diseases. Nat Rev Neurosci (2013) 2.05
The axonal transport of mitochondria. J Cell Sci (2012) 1.88
Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta. Proc Natl Acad Sci U S A (2009) 1.75
Mitochondrial trafficking in neurons. Cold Spring Harb Perspect Biol (2013) 1.69
The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity. J Neurosci Res (2009) 1.65
The role of GSK-3 in synaptic plasticity. Br J Pharmacol (2008) 1.52
1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C. Proc Natl Acad Sci U S A (2007) 1.51
Mitochondrial membrane potential in axons increases with local nerve growth factor or semaphorin signaling. J Neurosci (2008) 1.51
GSK-3 inhibitors induce chromosome instability. BMC Cell Biol (2007) 1.48
Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1. J Neurosci (2007) 1.39
Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases. J Neurosci (2011) 1.39
Axonal transport and the delivery of pre-synaptic components. Curr Opin Neurobiol (2008) 1.38
Quantitative and functional analyses of spastin in the nervous system: implications for hereditary spastic paraplegia. J Neurosci (2008) 1.32
A pivotal role of GSK-3 in synaptic plasticity. Front Mol Neurosci (2012) 1.23
Spatiotemporal regulation of ATP and Ca2+ dynamics in vertebrate rod and cone ribbon synapses. Mol Vis (2007) 1.18
Cdk5 Modulation of mitogen-activated protein kinase signaling regulates neuronal survival. Mol Biol Cell (2006) 1.16
Tau-based treatment strategies in neurodegenerative diseases. Neurotherapeutics (2008) 1.13
Mitochondria and neurotransmission: evacuating the synapse. Neuron (2005) 1.10
A Cdk5-dependent switch regulates Lis1/Ndel1/dynein-driven organelle transport in adult axons. J Neurosci (2011) 1.10
A peptide zipcode sufficient for anterograde transport within amyloid precursor protein. Proc Natl Acad Sci U S A (2006) 1.10
Mice lacking phosphatase PP2A subunit PR61/B'delta (Ppp2r5d) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3beta. Proc Natl Acad Sci U S A (2011) 1.09
Cytoskeletal requirements in axonal transport of slow component-b. J Neurosci (2008) 1.08
Role of GSK3 Signaling in Neuronal Morphogenesis. Front Mol Neurosci (2011) 1.06
The importance of tau phosphorylation for neurodegenerative diseases. Front Neurol (2013) 1.05
Cyclin-dependent kinase 5 regulates the polarized trafficking of neuropeptide-containing dense-core vesicles in Caenorhabditis elegans motor neurons. J Neurosci (2012) 1.05
Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport. Neurobiol Aging (2011) 1.04
The amyloid-beta precursor protein is phosphorylated via distinct pathways during differentiation, mitosis, stress, and degeneration. Mol Biol Cell (2007) 1.02
Molecular mechanisms of environmental enrichment: impairments in Akt/GSK3β, neurotrophin-3 and CREB signaling. PLoS One (2013) 0.97
Lemur tyrosine kinase-2 signalling regulates kinesin-1 light chain-2 phosphorylation and binding of Smad2 cargo. Oncogene (2011) 0.97
The sphingolipid psychosine inhibits fast axonal transport in Krabbe disease by activation of GSK3β and deregulation of molecular motors. J Neurosci (2013) 0.97
Vaccinia protein F12 has structural similarity to kinesin light chain and contains a motor binding motif required for virion export. PLoS Pathog (2010) 0.97
Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders. Future Neurol (2012) 0.95
Axonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system. Exp Neurol (2012) 0.95
Neurofilament tail phosphorylation: identity of the RT-97 phosphoepitope and regulation in neurons by cross-talk among proline-directed kinases. J Neurochem (2008) 0.93
Jump-starting kinesin. J Cell Biol (2007) 0.92
CDK-5 regulates the abundance of GLR-1 glutamate receptors in the ventral cord of Caenorhabditis elegans. Mol Biol Cell (2007) 0.92
Mitochondrial configurations in peripheral nerve suggest differential ATP production. J Struct Biol (2010) 0.91
Targeting Cdk5 activity in neuronal degeneration and regeneration. Cell Mol Neurobiol (2009) 0.91
Psychosine induces the dephosphorylation of neurofilaments by deregulation of PP1 and PP2A phosphatases. Neurobiol Dis (2012) 0.90
Crosstalk between Cdk5 and GSK3beta: Implications for Alzheimer's Disease. Front Mol Neurosci (2009) 0.89
The protein phosphatase-1/inhibitor-2 complex differentially regulates GSK3 dephosphorylation and increases sarcoplasmic/endoplasmic reticulum calcium ATPase 2 levels. Exp Cell Res (2006) 0.89
The kinesin-3 family motor KLP-4 regulates anterograde trafficking of GLR-1 glutamate receptors in the ventral nerve cord of Caenorhabditis elegans. Mol Biol Cell (2012) 0.87
Amyloid-β oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neurons. Mol Biol Cell (2013) 0.85
The Role of GSK3 in Presynaptic Function. Int J Alzheimers Dis (2011) 0.83
The NDR kinase DBF-2 is involved in regulation of mitosis, conidial development, and glycogen metabolism in Neurospora crassa. Eukaryot Cell (2009) 0.83
Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) [Eudract number: 2008-006891-31]. BMC Neurol (2011) 0.83
Stress-Induced CDK5 Activation Disrupts Axonal Transport via Lis1/Ndel1/Dynein. Cell Rep (2015) 0.82
Cyclin dependent kinase 5 is required for the normal development of oligodendrocytes and myelin formation. Dev Biol (2013) 0.82
Cdk5: mediator of neuronal development, death and the response to DNA damage. Mech Ageing Dev (2011) 0.80
At the Fulcrum in Health and Disease: Cdk5 and the Balancing Acts of Neuronal Structure and Physiology. Brain Disord Ther (2012) 0.79
Tau pathology-mediated presynaptic dysfunction. Neuroscience (2016) 0.78
TCTEX1D4, a novel protein phosphatase 1 interactor: connecting the phosphatase to the microtubule network. Biol Open (2013) 0.78
Amyloid-Beta Induced Changes in Vesicular Transport of BDNF in Hippocampal Neurons. Neural Plast (2016) 0.77
Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research? Neurobiol Dis (2017) 0.77
Emerging roles of Axin in cerebral cortical development. Front Cell Neurosci (2015) 0.77
A Tale of the Good and Bad: Remodeling of the Microtubule Network in the Brain by Cdk5. Mol Neurobiol (2016) 0.76
Prenatal alcohol exposure alters p35, CDK5 and GSK3β in the medial frontal cortex and hippocampus of adolescent mice. Toxicol Rep (2014) 0.76
FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications. Mol Psychiatry (2015) 0.76
Localization of axonal motor molecules machinery in neurodegenerative disorders. Int J Mol Sci (2012) 0.76
The Roles of Microtubule-Based Transport at Presynaptic Nerve Terminals. Front Synaptic Neurosci (2016) 0.75
Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition. Neurobiol Aging (2016) 0.75
Novel Non-phosphorylated Serine 9/21 GSK3β/α Antibodies: Expanding the Tools for Studying GSK3 Regulation. Front Mol Neurosci (2016) 0.75
Insulin signaling regulates a functional interaction between Adenomatous Polyposis Coli (APC) and cytoplasmic dynein. Mol Biol Cell (2017) 0.75
Temporal control of bidirectional lipid-droplet motion in Drosophila depends on the ratio of kinesin-1 and its co-factor Halo. J Cell Sci (2016) 0.75
C-terminal region of GADD34 regulates eIF2α dephosphorylation and cell proliferation in CHO-K1 cells. Cell Stress Chaperones (2015) 0.75
Neuropilin 2 Signaling Is Involved in Cell Positioning of Adult-born Neurons through Glycogen Synthase Kinase-3β (GSK3β). J Biol Chem (2016) 0.75
HIV Glycoprotein Gp120 Impairs Fast Axonal Transport by Activating Tak1 Signaling Pathways. ASN Neuro (2016) 0.75
Role of Glycogen Synthase Kinase-3β in APP Hyperphosphorylation Induced by NMDA Stimulation in Cortical Neurons. Pharmaceuticals (Basel) (2010) 0.75
CDK5-dependent activation of dynein in the axon initial segment regulates polarized cargo transport in neurons. Traffic (2017) 0.75
Regulation of motor proteins, axonal transport deficits and adult-onset neurodegenerative diseases. Neurobiol Dis (2017) 0.75
Identification of a novel force-generating protein, kinesin, involved in microtubule-based motility. Cell (1985) 13.73
Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature (2000) 8.37
The specificities of protein kinase inhibitors: an update. Biochem J (2003) 7.76
GSK3 takes centre stage more than 20 years after its discovery. Biochem J (2001) 7.74
Protein phosphatase 1--targeted in many directions. J Cell Sci (2002) 5.59
A novel brain ATPase with properties expected for the fast axonal transport motor. Nature (1985) 5.30
Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism. Nature (1989) 4.27
Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci U S A (1996) 4.16
p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature (1994) 3.95
Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature (1999) 3.50
Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J (2001) 3.22
Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron (2003) 2.97
Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron (1997) 2.96
A monoclonal antibody against kinesin inhibits both anterograde and retrograde fast axonal transport in squid axoplasm. Proc Natl Acad Sci U S A (1990) 2.89
Inhibition of cyclin-dependent kinases by purine analogues. Eur J Biochem (1994) 2.82
Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci (1999) 2.81
Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell (1992) 2.80
Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J (2002) 2.70
Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418. J Biol Chem (2003) 2.65
Identification of a neuronal Cdk5 activator-binding protein as Cdk5 inhibitor. J Biol Chem (2002) 2.43
Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. J Biol Chem (1994) 2.38
Monoclonal antibodies to kinesin heavy and light chains stain vesicle-like structures, but not microtubules, in cultured cells. J Cell Biol (1989) 2.38
Glycogen synthase kinase-3: properties, functions, and regulation. Chem Rev (2001) 2.36
Judging a protein by more than its name: GSK-3. Sci STKE (2001) 2.27
Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron (2003) 2.17
Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development (1993) 2.09
Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event. Biochem J (2004) 2.08
The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature (1998) 2.01
Video microscopy of fast axonal transport in extruded axoplasm: a new model for study of molecular mechanisms. Cell Motil (1985) 1.95
Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J Neurosci (2003) 1.91
Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta. J Biol Chem (2002) 1.88
p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci (2001) 1.87
Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression. Proc Natl Acad Sci U S A (1992) 1.85
Phosphorylation and inactivation of protein phosphatase 1 by cyclin-dependent kinases. Proc Natl Acad Sci U S A (1994) 1.81
Immunochemical analysis of kinesin light chain function. Mol Biol Cell (1997) 1.72
Nerve growth cones isolated from fetal rat brain: subcellular fractionation and characterization. Cell (1983) 1.62
Molecular genetics of kinesin light chains: generation of isoforms by alternative splicing. Proc Natl Acad Sci U S A (1991) 1.54
A specific light chain of kinesin associates with mitochondria in cultured cells. Mol Biol Cell (1998) 1.51
Tau in Alzheimer's disease. Trends Cell Biol (1998) 1.50
p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton. J Cell Sci (2000) 1.48
Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments. J Neurochem (2002) 1.42
Protein phosphatase inhibitor-1 and inhibitor-2 from rabbit skeletal muscle. Methods Enzymol (1988) 1.40
Release of kinesin from vesicles by hsc70 and regulation of fast axonal transport. Mol Biol Cell (2000) 1.39
Cdk5 behind the wheel: a role in trafficking and transport? Trends Cell Biol (2002) 1.38
Purification of type 1 protein (serine/threonine) phosphatases by microcystin-Sepharose affinity chromatography. FEBS Lett (1994) 1.35
Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: the effects on the organization and stability of microtubules. Neuroscience (1996) 1.33
Phosphorylation of neuronal kinesin heavy and light chains in vivo. J Neurochem (1993) 1.33
Fast axonal transport misregulation and Alzheimer's disease. Neuromolecular Med (2002) 1.28
Preferential addition of newly synthesized membrane protein at axonal growth cones. Nature (1995) 1.25
Regulation and functions of the glycogen synthase kinase-3 subfamily. Semin Cancer Biol (1994) 1.25
A-kinase anchoring protein AKAP220 binds to glycogen synthase kinase-3beta (GSK-3beta ) and mediates protein kinase A-dependent inhibition of GSK-3beta. J Biol Chem (2002) 1.22
Neuronal cdc2-like kinase. Trends Biochem Sci (1995) 1.21
Cdk5 on the brain. Cell Growth Differ (2001) 1.21
Ca2+-dependent dephosphorylation of kinesin heavy chain on beta-granules in pancreatic beta-cells. Implications for regulated beta-granule transport and insulin exocytosis. J Biol Chem (2002) 1.19
Copurification of kinesin polypeptides with microtubule-stimulated Mg-ATPase activity and kinetic analysis of enzymatic properties. Cell Motil Cytoskeleton (1989) 1.18
Axonal transport of mutant superoxide dismutase 1 and focal axonal abnormalities in the proximal axons of transgenic mice. Neurobiol Dis (1998) 1.16
Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice. J Neurosci (2003) 1.14
Association of the type 1 protein phosphatase PP1 with the A-kinase anchoring protein AKAP220. Curr Biol (1999) 1.13
A kinesin medley: biochemical and functional heterogeneity. Trends Cell Biol (1995) 1.11
Use of okadaic acid to inhibit protein phosphatases in intact cells. Methods Enzymol (1991) 1.08
GTP gamma S inhibits organelle transport along axonal microtubules. J Cell Biol (1993) 1.07
A role for cyclin-dependent kinase(s) in the modulation of fast anterograde axonal transport: effects defined by olomoucine and the APC tumor suppressor protein. J Neurosci (1998) 1.06
Regulation of kinesin: implications for neuronal development. Dev Neurosci (2001) 1.04
Divergent roles of GSK3 and CDK5 in APP processing. Biochem Biophys Res Commun (2003) 1.03
Neuronal Cdc2-like protein kinase (Cdk5/p25) is associated with protein phosphatase 1 and phosphorylates inhibitor-2. J Biol Chem (2001) 1.02
Structure and organization of membrane organelles along distal microtubule segments in growth cones. J Neurosci Res (1991) 1.01
Analysis of the expression, distribution and function of cyclin dependent kinase 5 (cdk5) in developing cerebellar macroneurons. J Cell Sci (1997) 0.98
Interaction of cyclin-dependent kinase 5 (Cdk5) and neuronal Cdk5 activator in bovine brain. J Biol Chem (1996) 0.98
The Cdk5-p35 kinase associates with the Golgi apparatus and regulates membrane traffic. EMBO Rep (2001) 0.96
P13suc1 associates with a cdc2-like kinase in a multimeric cytoskeletal complex in squid axoplasm. J Neurosci (1995) 0.93
Glycogen Synthase Kinase-3 Modulates Neurite Outgrowth in Cultured Neurons: Possible Implications for Neurite Pathology in Alzheimer's Disease. J Alzheimers Dis (1999) 0.92
Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice. Neurobiol Dis (2001) 0.92
Use of a synthetic peptide as a selective substrate for glycogen synthase kinase 3. Anal Biochem (1994) 0.88
Axonal transport and distribution of immunologically distinct kinesin heavy chains in rat neurons. J Neurosci Res (1999) 0.86
Demonstration of cyclin-dependent kinase inhibitory serine/threonine kinase in bovine thymus. J Biol Chem (1996) 0.83
Neurodegenerative diseases and model systems. Cold Spring Harb Symp Quant Biol (1996) 0.77
Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci (2010) 4.25
Axonal transport defects in neurodegenerative diseases. J Neurosci (2009) 2.74
Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J (2002) 2.70
Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J Biol Chem (2002) 2.67
Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron (2003) 2.50
JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport. Nat Neurosci (2006) 2.11
Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited. J Neurosci (2005) 2.04
Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat Neurosci (2009) 1.95
Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J Neurosci (2003) 1.91
Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta. J Biol Chem (2002) 1.88
Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron (2002) 1.82
Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice. Mol Cell Biol (2004) 1.81
Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubules. Neuron (2013) 1.78
The pathobiology of amyotrophic lateral sclerosis: a proteinopathy? J Neuropathol Exp Neurol (2005) 1.75
Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress. Mol Endocrinol (2007) 1.68
Treating the injured and burying the dead. Lancet (2005) 1.68
Difficult venous access in children: taking control. J Emerg Nurs (2009) 1.65
The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity. J Neurosci Res (2009) 1.65
Reelin modulates NMDA receptor activity in cortical neurons. J Neurosci (2005) 1.65
Cyclin-dependent kinase 5 regulates E2F transcription factor through phosphorylation of Rb protein in neurons. Cell Cycle (2012) 1.62
Interaction of reelin signaling and Lis1 in brain development. Nat Genet (2003) 1.56
Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments. Exp Cell Res (2007) 1.52
Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1. J Neurosci (2007) 1.39
Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases. J Neurosci (2011) 1.39
Cyclin-dependent kinase-5 is involved in neuregulin-dependent activation of phosphatidylinositol 3-kinase and Akt activity mediating neuronal survival. J Biol Chem (2003) 1.38
Does hope match the hype for targeted drugs? Lancet Oncol (2003) 1.38
Hiroshima: how much have we learned? Lancet (2005) 1.37
Cyclin-dependent kinase 5 activity regulates pain signaling. Proc Natl Acad Sci U S A (2006) 1.34
Quantitative and functional analyses of spastin in the nervous system: implications for hereditary spastic paraplegia. J Neurosci (2008) 1.32
Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1. Proc Natl Acad Sci U S A (2006) 1.31
Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J Biol Chem (2001) 1.30
Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35. J Biol Chem (2008) 1.30
F-spondin interaction with the apolipoprotein E receptor ApoEr2 affects processing of amyloid precursor protein. Mol Cell Biol (2005) 1.30
Fast axonal transport misregulation and Alzheimer's disease. Neuromolecular Med (2002) 1.28
A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. EMBO J (2004) 1.26
Conventional kinesin holoenzymes are composed of heavy and light chain homodimers. Biochemistry (2008) 1.25
Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features. J Neurochem (2010) 1.25
Cdk5 regulates the organization of Nestin and its association with p35. Mol Cell Biol (2003) 1.24
Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease. Am J Pathol (2004) 1.24
Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease. Brain (2012) 1.22
Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling. Proc Natl Acad Sci U S A (2005) 1.21
Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability. J Neurochem (2005) 1.20
Ca2+-dependent dephosphorylation of kinesin heavy chain on beta-granules in pancreatic beta-cells. Implications for regulated beta-granule transport and insulin exocytosis. J Biol Chem (2002) 1.19
Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy. Neurotoxicology (2013) 1.18
Tau binding to microtubules does not directly affect microtubule-based vesicle motility. J Neurosci Res (2007) 1.17
Cdk5 Modulation of mitogen-activated protein kinase signaling regulates neuronal survival. Mol Biol Cell (2006) 1.16
A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells. Eur J Biochem (2002) 1.16
Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J (2002) 1.13
Cyclin-dependent kinase 5 phosphorylation of human septin SEPT5 (hCDCrel-1) modulates exocytosis. J Neurosci (2008) 1.12
Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway. Mol Biol Cell (2012) 1.12
A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation. J Biol Chem (2010) 1.11
Synaptic transmission block by presynaptic injection of oligomeric amyloid beta. Proc Natl Acad Sci U S A (2009) 1.10
ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons. J Neurosci (2005) 1.09
Oxidative stress in neurodegeneration. Adv Pharmacol Sci (2011) 1.09
Fibroblast growth factor (FGF)-4 can induce proliferation of cardiac cushion mesenchymal cells during early valve leaflet formation. Dev Biol (2003) 1.08
Polyglutamine expansion diseases: failing to deliver. Trends Mol Med (2005) 1.08
Deregulated Cdk5 activity is involved in inducing Alzheimer's disease. Arch Med Res (2012) 1.08
Tau phosphorylation by cyclin-dependent kinase 5/p39 during brain development reduces its affinity for microtubules. J Biol Chem (2003) 1.07
Heat shock protein 70 prevents both tau aggregation and the inhibitory effects of preexisting tau aggregates on fast axonal transport. Biochemistry (2011) 1.05
Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35. J Neurosci Res (2002) 1.04
Cdk5 regulates axonal transport and phosphorylation of neurofilaments in cultured neurons. J Cell Sci (2004) 1.04
Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport. Neurobiol Aging (2011) 1.04
A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice. FASEB J (2012) 1.03
Transport of neurofilaments in growing axons requires microtubules but not actin filaments. J Neurosci Res (2005) 1.03
Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs. FASEB J (2011) 1.02
Reelin and cyclin-dependent kinase 5-dependent signals cooperate in regulating neuronal migration and synaptic transmission. J Neurosci (2004) 1.00
Perinatal abrogation of Cdk5 expression in brain results in neuronal migration defects. Proc Natl Acad Sci U S A (2004) 1.00
Myelin-associated glycoprotein modulates expression and phosphorylation of neuronal cytoskeletal elements and their associated kinases. J Neurochem (2002) 0.99
Cyclin-dependent kinase 5 in neurofilament function and regulation. Neurosignals (2003) 0.98
Molecular mechanisms of environmental enrichment: impairments in Akt/GSK3β, neurotrophin-3 and CREB signaling. PLoS One (2013) 0.97
Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase. PLoS One (2013) 0.97
The sphingolipid psychosine inhibits fast axonal transport in Krabbe disease by activation of GSK3β and deregulation of molecular motors. J Neurosci (2013) 0.97
Cyclin-dependent kinase 5 increases perikaryal neurofilament phosphorylation and inhibits neurofilament axonal transport in response to oxidative stress. J Neurosci Res (2004) 0.97
Sri Lanka banks on sustaining initial success. Lancet (2005) 0.97
Cyclin-dependent kinase 5 modulates the transcriptional activity of the mineralocorticoid receptor and regulates expression of brain-derived neurotrophic factor. Mol Endocrinol (2010) 0.96
Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide. Biochim Biophys Acta (2004) 0.96
The Pafah1b complex interacts with the reelin receptor VLDLR. PLoS One (2007) 0.96
Activity-driven dendritic remodeling requires microtubule-associated protein 1A. Curr Biol (2005) 0.96
The Reelin receptors Apoer2 and Vldlr coordinate the patterning of Purkinje cell topography in the developing mouse cerebellum. PLoS One (2008) 0.95
Axonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system. Exp Neurol (2012) 0.95